Aurolife Pharma, LLC: Drug Recall
Recall #D-0736-2022 · 03/17/2022
Class II: Risk
Recall Details
- Recall Number
- D-0736-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Aurolife Pharma, LLC
- Status
- Terminated
- Date Initiated
- 03/17/2022
- Location
- Dayton, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4080 bottles
Reason for Recall
Presence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room.
Product Description
Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, NDC 13107-014-01.
Distribution Pattern
Nationwide in the USA and Puerto Rico
Other Recalls by Aurolife Pharma, LLC
- Class III: Low Risk 05/18/2023
- Class II: Risk 12/16/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.